NanoViricides, Inc. (NYSE American.:NNVC) (the “Company”), a clinical stage global leader in broad-spectrum antiviral nanomedicines, reports today that it has now obtained a right of first refusal ...
In a notable development in the field of robotics, researchers at ETH Zurich and the Max Planck Institute for Intelligent Systems have unveiled a new robotic leg that mimics biological muscles more ...
In a notable development in the field of robotics, researchers at ETH Zurich and the Max Planck Institute for Intelligent Systems have unveiled a new robotic leg that mimics biological muscles more ...
Funded under the European cross-border cooperation Programme INTERREG VA France (Channel), as well as a €3.1 million contribution from the European Regional Development Fund (ERDF), the objective of ...